Lilly (Eli)LLYEarnings & Financial Report
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
LLY Q4 2025 Key Financial Metrics
营收
$19.3B
毛利润
$15.9B
营业利润
N/A
净利润
$6.6B
毛利率
82.5%
营业利润率
N/A
净利率
34.4%
同比增长
42.6%
EPS
$7.39
资金流向
Lilly (Eli) Q4 2025 Financial Summary
Lilly (Eli) reported revenue of $19.3B for Q4 2025, with a net profit of $6.6B (34.4% margin). Cost of goods sold was $3.4B, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $19.3B |
|---|---|
| Net Profit | $6.6B |
| Gross Margin | 82.5% |
| Operating Margin | N/A |
| Report Period | Q4 2025 |
Lilly (Eli) Annual Revenue by Year
Lilly (Eli) annual revenue history includes year-by-year totals (for example, 2025 revenue was $65.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $65.2B |
| 2024 | $45.0B |
| 2023 | $34.1B |
| 2022 | $28.5B |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $8.77B | $11.30B | $11.44B | $13.53B | $12.73B | $15.56B | $17.60B | $19.29B |
| 同比增长 | 26.0% | 36.0% | 20.4% | 44.7% | 45.2% | 37.6% | 53.9% | 42.6% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $63.94B | $71.87B | $75.61B | $78.71B | $89.39B | $100.92B | $114.94B | $112.48B |
| 总负债 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 股东权益 | $12.81B | $13.56B | $14.24B | $14.19B | $15.76B | $18.27B | $23.79B | $26.54B |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $1.17B | $1.47B | $3.71B | $2.47B | $1.67B | $3.09B | $8.84B | $3.22B |
Other Health Care Companies
BMY
Bristol Myers Squibb
营收
$12.5B
净利润
$1.1B
JNJ
Johnson & Johnson
营收
$24.6B
净利润
$5.1B
MRK
Merck & Co.
营收
$17.3B
净利润
$5.8B
PFE
Pfizer
营收
$16.7B
净利润
$3.5B
VTRS
Viatris
营收
$3.7B
净利润
N/A
ZTS
Zoetis
营收
$2.4B
净利润
$603.0M
ABT
Abbott Laboratories
营收
$11.4B
净利润
$1.6B
ABBV
AbbVie
营收
$15.8B
净利润
$186.0M
A
Agilent Technologies
营收
$1.9B
净利润
$434.0M
ALGN
Align Technology
营收
$995.7M
净利润
$56.8M